InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,872.11
(
-0.46%
)
Post# of 43292
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: None

Wednesday, 10/21/2020 5:36:20 AM

Wednesday, October 21, 2020 5:36:20 AM

Post# of 43292
Cantor Fitzgerald 10/20/20 :
“Expecting positive Phase 3 data for COVID-19 opportunity. Lenzilumab could be the
first antibody approved for cytokine storm associated with COVD-19, and HGEN could
make up to $1B in sales in 2021”
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up